Cox N H, Forsyth A
Department of Dermatology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Contact Dermatitis. 1988 Apr;18(4):229-33. doi: 10.1111/j.1600-0536.1988.tb02809.x.
Thiomersal is the preservative in all toxoid vaccines routinely administered to children in the UK, but exposure from other sources is uncommon. Delayed hypersensitivity to thiomersal was demonstrated in 1% of individuals attending the Contact Dermatitis Investigation Unit, and 50 of these patients with positive patch tests to thiomersal were studied. Cross-reaction with other mercurials occurred in 17 of 29 patients tested (59%). 31 of the patients replied to a questionnaire regarding vaccination reactions, and were compared with case-controls matched for age, sex, and site of dermatitis. 4 patients in each group reported reactions to vaccines which contained thiomersal, suggesting that thiomersal hypersensitivity was not associated with an increased risk of vaccination reactions. However, individual cases of severe reactions to thiomersal demonstrate a need for vaccines with an alternative preservative.
硫柳汞是英国常规给儿童接种的所有类毒素疫苗中的防腐剂,但来自其他来源的接触并不常见。在接触性皮炎调查单位就诊的个体中,有1%的人对硫柳汞表现出迟发型超敏反应,对其中50例硫柳汞斑贴试验呈阳性的患者进行了研究。在29例接受检测的患者中,有17例(59%)与其他汞剂发生交叉反应。31例患者回复了一份关于疫苗接种反应的问卷,并与年龄、性别和皮炎部位相匹配的病例对照进行比较。每组中有4例患者报告了对含硫柳汞疫苗的反应,这表明硫柳汞超敏反应与疫苗接种反应风险增加无关。然而,个别对硫柳汞严重反应的病例表明需要使用替代防腐剂的疫苗。